Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 11
2003 8
2004 8
2005 14
2006 14
2007 7
2008 8
2009 9
2010 9
2011 7
2012 7
2013 9
2014 7
2015 10
2016 15
2017 19
2018 14
2019 16
2020 4
2021 5
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

189 results

Results by year

Filters applied: . Clear all
Page 1
The future of affordable cancer immunotherapy.
Schaft N, Dörrie J, Schuler G, Schuler-Thurner B, Sallam H, Klein S, Eisenberg G, Frankenburg S, Lotem M, Khatib A. Schaft N, et al. Among authors: schuler g. Front Immunol. 2023 Sep 6;14:1248867. doi: 10.3389/fimmu.2023.1248867. eCollection 2023. Front Immunol. 2023. PMID: 37736099 Free PMC article. Review.
Autologous regulatory T-cell transfer in refractory ulcerative colitis with concomitant primary sclerosing cholangitis.
Voskens C, Stoica D, Rosenberg M, Vitali F, Zundler S, Ganslmayer M, Knott H, Wiesinger M, Wunder J, Kummer M, Siegmund B, Schnoy E, Rath T, Hartmann A, Hackstein H, Schuler-Thurner B, Berking C, Schuler G, Atreya R, Neurath MF. Voskens C, et al. Among authors: schuler g. Gut. 2023 Jan;72(1):49-53. doi: 10.1136/gutjnl-2022-327075. Epub 2022 Apr 15. Gut. 2023. PMID: 35428657 Free PMC article. Clinical Trial.
Safety and tolerability of a single infusion of autologous ex vivo expanded regulatory T cells in adults with ulcerative colitis (ER-TREG 01): protocol of a phase 1, open-label, fast-track dose-escalation clinical trial.
Voskens CJ, Stoica D, Roessner S, Vitali F, Zundler S, Rosenberg M, Wiesinger M, Wunder J, Siegmund B, Schuler-Thurner B, Schuler G, Berking C, Atreya R, Neurath MF. Voskens CJ, et al. Among authors: schuler g. BMJ Open. 2021 Dec 8;11(12):e049208. doi: 10.1136/bmjopen-2021-049208. BMJ Open. 2021. PMID: 34880013 Free PMC article.
Assessment of sorafenib induced changes in tumor perfusion of uveal melanoma metastases with dynamic contrast-enhanced ultrasound (DCE-US).
Wildner D, Heinzerling L, Scheulen ME, Kaempgen E, Schuler G, Strobel D, Janka R, Neurath MF, Sturm J, Knieling F. Wildner D, et al. Among authors: schuler g. J Cancer Res Clin Oncol. 2022 Apr;148(4):955-965. doi: 10.1007/s00432-021-03666-8. Epub 2021 May 28. J Cancer Res Clin Oncol. 2022. PMID: 34050396 Free PMC article.
Cryopreservation impairs 3-D migration and cytotoxicity of natural killer cells.
Mark C, Czerwinski T, Roessner S, Mainka A, Hörsch F, Heublein L, Winterl A, Sanokowski S, Richter S, Bauer N, Angelini TE, Schuler G, Fabry B, Voskens CJ. Mark C, et al. Among authors: schuler g. Nat Commun. 2020 Oct 16;11(1):5224. doi: 10.1038/s41467-020-19094-0. Nat Commun. 2020. PMID: 33067467 Free PMC article.
189 results